These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32093644)

  • 1. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma.
    Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Loilome W
    BMC Cancer; 2020 Feb; 20(1):154. PubMed ID: 32093644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
    Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
    J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.
    Ohta S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Wada Y; Yamashita S; Bando Y; Shimada M
    Anticancer Res; 2019 Nov; 39(11):6025-6033. PubMed ID: 31704828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
    Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
    J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
    Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
    Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of EGFR family gene aberrations in cholangiocarcinoma.
    Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B
    Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin promotes cholangiocarcinoma metastasis via the EGFR/AKT pathway.
    Su ZJ; Liu XY; Zhang JH; Ke SY; Fei HJ
    Gene; 2019 Mar; 687():143-150. PubMed ID: 30359740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.
    Loosen SH; Roderburg C; Kauertz KL; Koch A; Vucur M; Schneider AT; Binnebösel M; Ulmer TF; Lurje G; Schoening W; Tacke F; Trautwein C; Longerich T; Dejong CH; Neumann UP; Luedde T
    Sci Rep; 2017 Dec; 7(1):16975. PubMed ID: 29208940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
    J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
    Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
    Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
    Tang X; Zhang J; Chen Y; Lan Z; Wang C
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma.
    Deng Y; Chen Y
    Oncol Res Treat; 2017; 40(3):128-132. PubMed ID: 28118648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Peritumoral IL-17-Positive Cells and IL-17 Axis in Patients with Intrahepatic Cholangiocarcinoma.
    Asukai K; Kawamoto K; Eguchi H; Konno M; Nishida N; Koseki J; Noguchi K; Hasegawa S; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Noda T; Wada H; Gotoh K; Marubashi S; Nagano H; Doki Y; Mori M; Ishii H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1524-31. PubMed ID: 26228109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance.
    Suksawat M; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Titapun A; Koonmee S; Loilome W
    Parasitol Int; 2017 Aug; 66(4):486-493. PubMed ID: 27143607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.